The malaria drug hydroxychloroquine (HCQ) may have a beneficial effect on corona patients if they receive it from the first day of their hospitalization. This is evident from a study in fourteen Dutch hospitals. The NOS reports that.
The risk of ending up in intensive care was more than half lower in patients who received the drug. Use of the drug did not reduce covid-19 mortality. No significant effect was evident in patients receiving the related chloroquine. The researchers emphasize that their results must be confirmed in a new study.
View the live blog here Friday, October 9